Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
Recent: |
|
Past: |
|
Sequoia Capital Southeast Asia has led credit and payments fintech Shift’s $27 million Series C funding round. → Read More
Local tech companies will not escape the sales cycle slowdown being experienced by their US peers, analysts say. → Read More
FoodByUs has closed a $12 million Series B funding round after a year of pitching to investors. → Read More
Sleep disorder and breathing devices company ResMed banked $2.8 billion in revenue in the first half as demand surges as its biggest competitor remains out of the market. → Read More
The software logistic giant is spending $325 million to buy US-based Envase Technologies. → Read More
Paul Perreault is stepping down as chief executive of the blood products giant after more than a decade at the helm. → Read More
The blood products giant, and the country’s third-biggest company, has promoted its chief operating officer Paul McKenzie to chief executive. → Read More
Accelerator program Startmate has raised more capital in 2022 than it had in its decade-long history to this point. → Read More
Alludo has gazumped Potentia’s upgraded offer for Nitro, upping its bid by 7.5 per cent to $2.15 a share. → Read More
The co-working space turned start-up hub has named Tiliter co-founder Martin Karafilis as its new chief executive. → Read More
Incode is one of a new group of companies pledging to help corporations prevent identity fraud using biometric data. → Read More
Peter and James Iansek founded Operative Intelligence to help customer contact centres resolve problems faster. → Read More
The proposed $170 million acquisition of a Danish hearing loss device maker is in the ACCC’s spotlight. → Read More
The diagnostics giant has acquired a 19.99 per cent stake in the small-cap biotech and is also seeking approval for another 5 per cent. → Read More
The mattress and furniture ecommerce company is bolstering its executive ranks ahead of a big 2023. → Read More
Steve Vamos announced his resignation from Xero on Thursday, while revealing the company had 30 per cent revenue growth in the half to $NZ658.5 million. → Read More
The biotech giant wants to beef up its mRNA capabilities and has signed a deal with Nasdaq-listed company, Arcturus. → Read More
PolyNovo has surpassed $5 million in monthly sales for the first time after expanding its US sales team. → Read More
Global buyout bigwig CVC Capital Partners is cashed up and ready for big Australian M&A deals. → Read More
There’s nothing muddying the waters with this deal. → Read More